Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

about

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

Item

http://www.wikidata.org/entity/Q61713089

description

clinical trial

@en

klinisch onderzoek

@nl

name

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@en

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@nl

type

Item

label

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@en

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@nl

prefLabel

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@en

Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced Melanoma

@nl

P1476

A Randomized Phase II Study of ...... ron-Alpha in Advanced Melanoma

@en

P17

Ameeriga Ütisriigiq

P2899

http://www.w3.org/2001/XMLSchema#decimal

P3098

NCT01708941

http://www.w3.org/2001/XMLSchema#string

P31

clinical trial

P4844

Interferon-alpha

P580

2012-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P582

2017-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6099

phase II clinical trial

P6153

Hurley Medical Center

Decatur Memorial Hospital

University of Toledo

University of Pittsburgh

MetroHealth Medical Center

Sky Ridge Medical Center

Iowa Methodist Medical Center

Aurora Sinai Medical Center

Northwestern University

Porter Adventist Hospital

P8363

interventional study

P859

National Cancer Institute